Early Genetic Screening Test
for Nasopharyngeal Cancer
An innovation paradigm shift in the effective management of nasopharyngeal cancer (NPC) by Early Detection.
Accurate, Simple, Non-Invasive
NP Screen™ has been clinically proven to provide a 99% accuracy level in sensitivity and specificity in detection of nasopharyngeal cancer.
Benefits of NP Screen™
- Early Detection
NP Screen™ diagnoses the earliest form of cancer in NPC, by detecting and quantifying and quantify the carcinoma in-situ or cancer cells from patients. Utilizing the Q-PCR process, NP Screen™ pinpoints the cells with NPC tumor markers. With EBV DNA integration, it can detect the earliest stage of NPC even when it is not visible on or below the skin surface.Learn more >
NP Screen™ is a user-pay test. Currently, NP Screen™ is available in U.S., and Canada for $300. In Hong Kong and other regions, price may vary.
Find a Location
NP Screen™ does not require a physician referral. If you are interested in screening for nasopharyngeal cancer, simply call one of our clinic locations and book an appointment for NP Screen™.